Core Viewpoint - The company reported a significant increase in revenue and profit for the six months ending September 30, 2025, indicating strong financial performance compared to the previous year [1] Financial Performance - Revenue for the six months was approximately HKD 430 million, an increase of about 7.7% from approximately HKD 400 million in the same period of 2024 [1] - Operating profit for the same period was around HKD 150 million, reflecting a growth of approximately 23.8% from about HKD 122 million in 2024 [1] - Profit attributable to equity holders was approximately HKD 115 million, which is a 20.0% increase from around HKD 95.9 million in 2024 [1] Dividend Declaration - The board declared an interim dividend of HKD 0.0975 per ordinary share, totaling approximately HKD 8.01 million, which is an increase of about 77.3% compared to HKD 0.055 per ordinary share (totaling approximately HKD 45.2 million) in 2024 [1]
健倍苗苗(02161.HK)中期净利润约为1.15亿港元 同比增加20.0%